duloxetine hydrochloride has been researched along with Idiopathic Parkinson Disease in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Bruno, V; Farcy, N; Karnik, V; Zamorano, C | 1 |
Nagamine, T | 1 |
Ando, R; Iwaki, H; Miyaue, N; Nagai, M; Nishikawa, N; Nomoto, M; Tada, S; Tsujii, T; Yabe, H; Yamanishi, Y | 1 |
Arai, A; Baba, M; Funamizu, Y; Haga, R; Kon, T; Nishijima, H; Nunomura, JI; Suzuki, C; Tomiyama, M; Ueno, T | 1 |
Buhidma, Y; Duty, S; Leta, V; Malcangio, M; Ray Chaudhuri, K; Rukavina, K; Sportelli, C | 1 |
Bandettini di Poggio, M; Bruno, C; Meschini, MC; Nesti, C; Santorelli, FM; Schenone, A | 1 |
Avanzino, L; Bonuccelli, U; Caltagirone, C; Ceravolo, R; Dell'Agnello, G; Fabbrini, G; Guadagna, M; Mancini, M; Meco, G; Morgante, F; Pierantozzi, M; Rossi, A; Ruggieri, S; Silvestrini, M; Spezia, R; Stocchi, F; Tessitore, A | 1 |
Pae, CU | 1 |
2 review(s) available for duloxetine hydrochloride and Idiopathic Parkinson Disease
Article | Year |
---|---|
Current Status of Pain Management in Parkinson's Disease.
Topics: Acetylcholine Release Inhibitors; Alanine; Analgesics; Antiparkinson Agents; Apomorphine; Benzylamines; Botulinum Toxins, Type A; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Duloxetine Hydrochloride; Humans; Levodopa; Naloxone; Oxycodone; Pain; Pain Management; Pain Measurement; Pain Threshold; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes | 2020 |
Pain in Parkinson's disease: new concepts in pathogenesis and treatment.
Topics: Analgesics; Botulinum Toxins; Chronic Pain; Deep Brain Stimulation; Duloxetine Hydrochloride; Humans; Naloxone; Oxycodone; Pain Management; Parkinson Disease | 2019 |
3 trial(s) available for duloxetine hydrochloride and Idiopathic Parkinson Disease
Article | Year |
---|---|
A double-blind, randomized controlled trial of duloxetine for pain in Parkinson's disease.
Topics: Dopamine Agents; Double-Blind Method; Duloxetine Hydrochloride; Humans; Pain; Parkinson Disease; Treatment Outcome | 2020 |
Effects of duloxetine on motor and mood symptoms in Parkinson's disease: An open-label clinical experience.
Topics: Affect; Aged; Antiparkinson Agents; Drug Therapy, Combination; Duloxetine Hydrochloride; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome | 2017 |
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Quality of Life; Thiophenes; Treatment Outcome | 2012 |
3 other study(ies) available for duloxetine hydrochloride and Idiopathic Parkinson Disease
Article | Year |
---|---|
Duloxetine, a serotonin and norepinephrine reuptake inhibitor, may be a double-edged sword for patients with advanced Parkinson's disease.
Topics: Aged; Depression; Duloxetine Hydrochloride; Dyskinesia, Drug-Induced; Humans; Male; Parkinson Disease; Serotonin and Noradrenaline Reuptake Inhibitors | 2020 |
Dopamine-agonist responsive Parkinsonism in a patient with the SANDO syndrome caused by POLG mutation.
Topics: Benzothiazoles; DNA Mutational Analysis; DNA Polymerase gamma; DNA-Directed DNA Polymerase; Dopamine Agonists; Duloxetine Hydrochloride; Dysarthria; Female; Hereditary Sensory and Motor Neuropathy; Humans; Middle Aged; Mitochondria; Ophthalmoplegia; Parkinson Disease; Pramipexole; Thiophenes; Tomography, Emission-Computed, Single-Photon | 2013 |
Use of antidepressants for depression in patients with Parkinson's disease.
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Humans; Parkinson Disease; Positron-Emission Tomography; Thiophenes | 2013 |